Hall-of-Famer Brian Dawkins Teams with CORE Kidney to Promote Proper Testing

Stock.adobe.com

Eli Lilly and Company, Boehringer Ingelheim, and CORE Kidney are teaming up to promote complete testing for kidney disease.¹ The campaign on focused on educating potential patients about the fact that it takes two separate tests, blood and urine, to fully test for the disease. The three companies will launch the campaign at the 2025 Tournament of Roses parade.

In a press release, pro football hall of famer Brian Dawkins said, “With my parents having conditions that put them at risk for CKD, I feel proud and blessed to help bring awareness to a cause that hits home for me. We are providing knowledge, which becomes very powerful when applied to your health!"

Dawkins is helping promote the campaign, which will include a float in the 2025 Rose Parade. The float will be titled “It’s In Your Hands: It Takes 2” and will represent the patient journey.

Dr. Anjay Rastogi, MD, PhD, is director of the CORE Kidney Program, as well as being a professor and clinical chief of nephrology at the David Geffen School of Medicine at UCLA Health. In the same press release, he said, “Two of the key drivers of the low diagnostic rates are the lack of awareness and inadequate testing. In fact, less than 20% of individuals at-risk for kidney disease receive both blood and urine tests. This collaboration with Boehringer Ingelheim, Lilly, and Brian Dawkins is a tremendous opportunity to underscore the importance of not only the doctor-patient relationship but also guideline directed testing when it comes to kidney health."

Andy Vicari, vice president at head of the US BI/Lilly alliance at Lilly also said, “Acknowledging the control that individuals have over their own health is essential. Through our partnership with CORE Kidney, we aim to inspire those at-risk for chronic kidney disease to take action. When people advocate for their health and collaborate with their healthcare providers, they can pave the way for a healthier future."

Senior vice president of cardiovascular, renal, and metabolic franchise at Boehringer Ingelheim Brian DiDonato said, “Music is universal, making it a powerful vehicle for our message of working with your doctor to request complete testing for kidney disease. We're thrilled to raise the volume of this message with our remix and partnership with Brian Dawkins, and hope that by seeing our float, those at risk feel empowered to prioritize their kidney and heart health. Because not only does complete testing–blood and urine tests–help your kidneys, but it can also uncover hidden cardiovascular risks."

Source

1. CORE Kidney, Boehringer Ingelheim and Lilly Are Turning Up the Volume on Kidney Health at the 2025 Tournament of Roses® Parade. Lilly. December 9, 2024. https://investor.lilly.com/news-releases/news-release-details/core-kidney-boehringer-ingelheim-and-lilly-are-turning-volume